InflaRx N.V. Stock News

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although Amazon.com...

Inflarx NV (NASDAQ:IFRX)’s share price gapped up prior to trading on Thursday . The stock had previously closed at $4.92, but opened at $5.73. Inflarx shares last traded at $4.97, with a volume of 7

Luckin Coffee (NASDAQ:LK) -84% on fraud finding.Golar LNG Partners (NASDAQ:GMLP) -55% on dividend cut.Safe-T Group (NASDAQ:SFET) -28% after pricing direct offering.Dynatronics (NASDAQ:DYNT) -22%�

Gainers InflaRx N.V. (NASDAQ: IFRX) shares climbed 50% to close at $5.73 on Wednesday after the company said it has enrolled and dosed the first patient into a randomized...

Shares of InflaRx and BioNTech diverged Wednesday after the biotech companies unveiled updates for their coronavirus treatment and vaccine, respectively. InflaRx rocketed as BioNTech fell.

Toward the end of trading Wednesday, the Dow traded down 3.66% to 21,118 while the NASDAQ fell 3.53% to 7428.25. The S&P also fell, dropping 3.84% to 2,485.38. The U.S. is now...

Gainers InflaRx N.V. (NASDAQ: IFRX) shares jumped 56.8% to $5.99 after the company said it has enrolled and dosed the first patient into a randomized clinical trial...

Midway through trading Wednesday, the Dow traded down 2.67% to 21331.51 while the NASDAQ fell 2.33% to 7,520.78. The S&P also fell, dropping 2.99% to 2,507.22. The U.S. is now...

Following the market opening Wednesday, the Dow traded down 2.7% to 21,324.83 while the NASDAQ fell 2.44% to 7,511.97. The S&P also fell, dropping 2.98% to 2,507.50. The U.S....

InflaRx N.V. (NASDAQ:IFRX) +54% with doses of first COVID-19 with IFX-1.Qumu (NASDAQ:QUMU) +39%.Chembio Diagnostics (NASDAQ:CEMI) +26% on launching rapid COVID-19 blood test.Safe-T Group (NASDAQ:SFE

Gainers • InflaRx, Inc. (NASDAQ:IFRX) shares increased by 93.19% to $7.38 during Wednesday's pre-market session. • Chembio Diagnostics, Inc. (NASDAQ:CEMI) shares...

Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs March 31) * Athersys Inc (NASDAQ: ATHX) * Forty Seven Inc (NA

Gainers InflaRx N.V. (NASDAQ: IFRX) shares rose 133% to $8.90 in pre-market trading after the company announced it dosed the first patient in a clinical study with IFX-1 in...

Inflarx NV (NASDAQ:IFRX) has been given an average recommendation of “Hold” by the ten analysts that are presently covering the firm, Marketbeat reports. Two analysts have rated the stock with a s